Vimedimex Medi-Pharma JSC (HOSE:VMD)
14,950
0.00 (0.00%)
At close: Apr 28, 2026
Vimedimex Medi-Pharma JSC Cash Flow Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Net Income | 42,361 | 23,194 | 25,482 | 34,818 | 19,995 | Upgrade
|
| Depreciation & Amortization | 3,958 | 19,638 | 18,792 | 19,251 | 19,051 | Upgrade
|
| Other Amortization | - | - | 604.9 | - | 369.31 | Upgrade
|
| Loss (Gain) From Sale of Assets | -7,977 | -6,457 | -15,631 | -7,121 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | - | -5,531 | Upgrade
|
| Other Operating Activities | -1,893 | 6,129 | 1,431 | -3,364 | -29,865 | Upgrade
|
| Change in Accounts Receivable | -1,039,280 | 367,260 | 551,782 | 1,378,506 | 1,182,198 | Upgrade
|
| Change in Inventory | 70,331 | 162,999 | 698,451 | 1,593,122 | 1,367,202 | Upgrade
|
| Change in Accounts Payable | 943,064 | -459,010 | -1,266,375 | -2,310,209 | -2,979,235 | Upgrade
|
| Change in Other Net Operating Assets | - | 4,921 | 7,333 | -2,920 | 3,799 | Upgrade
|
| Operating Cash Flow | 10,565 | 118,674 | 21,872 | 702,082 | -422,016 | Upgrade
|
| Operating Cash Flow Growth | -91.10% | 442.59% | -96.89% | - | - | Upgrade
|
| Capital Expenditures | - | -7,001 | -16,329 | -5,163 | -20,468 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 4.82 | 166.54 | 10.09 | Upgrade
|
| Investment in Securities | - | - | - | -1,380 | - | Upgrade
|
| Other Investing Activities | 6,836 | 6,457 | 11,000 | 6,263 | 14,727 | Upgrade
|
| Investing Cash Flow | -183,044 | 4,084 | -2,278 | -11,650 | -5,673 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | 1,736,174 | Upgrade
|
| Long-Term Debt Issued | - | - | 338,500 | 634,900 | - | Upgrade
|
| Total Debt Issued | - | - | 338,500 | 634,900 | 1,736,174 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -1,468,800 | Upgrade
|
| Long-Term Debt Repaid | - | - | -338,500 | -1,247,274 | - | Upgrade
|
| Total Debt Repaid | - | - | -338,500 | -1,247,274 | -1,468,800 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | - | -612,374 | 267,374 | Upgrade
|
| Issuance of Common Stock | - | - | 6,710 | 2,000 | 46,410 | Upgrade
|
| Common Dividends Paid | - | -31,443 | -30,178 | -15,116 | -40,067 | Upgrade
|
| Other Financing Activities | - | - | - | - | 0 | Upgrade
|
| Financing Cash Flow | - | -31,443 | -23,468 | -625,490 | 273,717 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | - | - | -12.15 | -0.74 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | - | 0 | Upgrade
|
| Net Cash Flow | -172,479 | 91,315 | -3,875 | 64,930 | -153,973 | Upgrade
|
| Free Cash Flow | 10,565 | 111,673 | 5,543 | 696,919 | -442,484 | Upgrade
|
| Free Cash Flow Growth | -90.54% | 1914.81% | -99.20% | - | - | Upgrade
|
| Free Cash Flow Margin | 1.30% | 8.94% | 0.16% | 9.85% | -3.59% | Upgrade
|
| Free Cash Flow Per Share | 684.23 | 7232.56 | 358.89 | 45136.46 | -28657.78 | Upgrade
|
| Cash Interest Paid | - | 3,703 | 1,749 | 7,612 | 13,200 | Upgrade
|
| Cash Income Tax Paid | 6,241 | 6,306 | 13,709 | 5,057 | 15,850 | Upgrade
|
| Levered Free Cash Flow | 84,166 | 90,510 | 10,091 | 690,144 | -384,347 | Upgrade
|
| Unlevered Free Cash Flow | 84,166 | 92,825 | 11,184 | 693,335 | -374,507 | Upgrade
|
| Change in Working Capital | -25,885 | 76,171 | -8,808 | 658,498 | -426,036 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.